|
USP28 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.97389999998266E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.30959999994551E-06 |
| Normal-vs-Stage2 |
4.659200E-01 |
| Normal-vs-Stage3 |
1.883710E-02 |
| Normal-vs-Stage4 |
1.370160E-02 |
| Stage1-vs-Stage2 |
1.712010E-01 |
| Stage1-vs-Stage3 |
7.946200E-01 |
| Stage1-vs-Stage4 |
6.158000E-01 |
| Stage2-vs-Stage3 |
3.869400E-01 |
| Stage2-vs-Stage4 |
2.545000E-01 |
| Stage3-vs-Stage4 |
5.363800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54286999999309E-05 |
| Normal-vs-AfricanAmerican |
5.177200E-03 |
| Normal-vs-Asian |
2.931600E-02 |
| Caucasian-vs-AfricanAmerican |
8.163200E-01 |
| Caucasian-vs-Asian |
9.853800E-01 |
| AfricanAmerican-vs-Asian |
9.515800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.31290000882478E-09 |
| Normal-vs-Female |
9.476600E-01 |
| Male-vs-Female |
2.997700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.400600E-04 |
| Normal-vs-Extreme_Weight |
4.69629999999555E-07 |
| Normal-vs-Obese |
4.415900E-02 |
| Normal-vs-Extreme_Obese |
2.822000E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.111400E-01 |
| Normal_Weight-vs-Obese |
1.603020E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.145800E-01 |
| Extreme_Weight-vs-Obese |
1.949640E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.266400E-01 |
| Obese-vs-Extreme_Obese |
6.784000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.574400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.960600E-03 |
| Normal-vs-Age(61-80Yrs) |
8.74750000212643E-08 |
| Normal-vs-Age(81-100Yrs) |
2.242400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.131700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.286000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.560350E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.003700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.363350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.988000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.3527000044038E-08 |
| Normal-VS-Type2 PRCC |
3.62819999999431E-06 |
| Normal-VS-KIRP CIMP |
7.591800E-02 |
| Normal-VS-Unclassified PRCC |
2.406000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.105600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.276160E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.388600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.142350E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.458200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.904400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.32059999999823E-05 |
| Normal-vs-N1 |
2.883400E-01 |
| Normal-vs-N2 |
8.13849999999894E-05 |
| N0-vs-N1 |
1.350980E-01 |
| N0-vs-N2 |
3.317200E-01 |
| N1-vs-N2 |
8.077800E-03 |
|
|
